Their proprietary diagnostic format provides a colorimetric readout in minutes, visual to the naked eye, without the need for any reagents, readers, instruments, equipment, or training, enabling clinicians to extend the point-of-care and laypeople to self-administer at the point-of-need. Chemeleon's diagnostics combine highly-selective molecular receptors with colorimetric nanomaterial reporters to provide immediate, actionable diagnosis to improve patient treatments and outcomes while reducing costs. They have developed a chemical sensor that can detect hazardous chemicals in virtually any environment, from clinical to third-world settings, using highly-selective molecular receptors and colorimetric nanomaterial reporters. Their platform technology can revolutionize healthcare and chemical detection by providing rapid, simple, and inexpensive diagnostics that are ASSURED (Affordable, Sensitive, Specific, User-friendly, Rapid and robust, Equipment-free, and Deliverable to end-users) and obviating the need for slow, complex, and expensive lab analysis.